Klotz, L., Grützke, B., Eveslage, M., Deppe, M., Gross, C. C., Kirstein, L., . . . Wiendl, H. (2015). Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor). BMC Neurol.
Citação norma ChicagoKlotz, Luisa, et al. "Assessment of Immune Functions and MRI Disease Activity in Relapsing-remitting Multiple Sclerosis Patients Switching From Natalizumab to Fingolimod (ToFingo-Successor)." BMC Neurol 2015.
MLA CitationKlotz, Luisa, et al. "Assessment of Immune Functions and MRI Disease Activity in Relapsing-remitting Multiple Sclerosis Patients Switching From Natalizumab to Fingolimod (ToFingo-Successor)." BMC Neurol 2015.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.